• 1. An integrated droplet-digital microfluidic system for on-demand droplet creation, mixing, incubation, and sorting?
  Lab Chip, 2019,19, 524-535
• 2. An amorphous Cu–In–S nanoparticle-based precursor ink with improved atom economy for CuInSe2 solar cells with 10.85% efficiency?
  Green Chem., 2017,19, 1268-1277
• 3. An anti-leakage liquid metal thermal interface material
  Kaiyuan Huang,Wangkang Qiu,Meilian Ou,Xiaorui Liu,Zenan Liao,Sheng Chu RSC Adv., 2020,10, 18824-18829
• 4. An atom efficient route to N-aryl and N-alkyl pyrrolines by transition metal catalysis?
  Supaporn Sawadjoon,Joseph S. M. Samec Org. Biomol. Chem., 2011,9, 2548-2554
• 5. An approach to C–N activation: coupling of arenesulfonyl hydrazides and arenesulfonyl chlorides with tert-amines via a metal-, oxidant- and halogen-free anodic oxidation??
  M. Sheykhan,S. Khani,S. Shaabanzadeh,M. Joafshan Green Chem., 2017,19, 5940-5948

• Solvents and Organic Chemicals Organic Compounds Lipids and lipid-like molecules Prenol lipids Diterpene glycosides
• Solvents and Organic Chemicals Organic Compounds Lipids and lipid-like molecules Prenol lipids Terpene glycosides Diterpene glycosides
• Diterpenoids

Rebaudioside D (CAS No: 63279-13-0) - A Comprehensive Overview

Rebaudioside D, with the chemical identifier CAS No: 63279-13-0, is a naturally occurring glycoside that has garnered significant attention in the field of pharmaceuticals and nutraceuticals. This compound is a derivative of steviol glycosides, which are found in the leaves of the Stevia rebaudiana plant. Known for its sweetening properties without the caloric content associated with traditional sugars, Rebaudioside D has become a popular alternative sweetener in various food and beverage products. This article provides an in-depth exploration of Rebaudioside D, including its chemical structure, biological activities, recent research findings, and potential applications.

The molecular structure of Rebaudioside D consists of a steviol aglycone core linked to a glucose moiety. This glycosidic bond contributes to its stability and bioavailability, making it an attractive candidate for various applications. The unique chemical composition of Rebaudioside D allows it to interact with taste receptors in the human mouth, providing a sweet sensation that is comparable to that of sugar but without the associated metabolic effects.

In recent years, there has been a surge in research focused on the health benefits of natural sweeteners like Rebaudioside D. Studies have demonstrated that this compound exhibits several pharmacological properties beyond its primary role as a sweetener. For instance, research indicates that Rebaudioside D may possess anti-inflammatory, antioxidant, and hypoglycemic effects. These findings have prompted investigations into its potential therapeutic applications in managing chronic diseases such as diabetes and cardiovascular disorders.

The anti-inflammatory properties of Rebaudioside D have been particularly well-documented. In vitro studies have shown that this compound can inhibit the production of pro-inflammatory cytokines such as tumor necrosis factor-alpha (TNF-α) and interleukin-6 (IL-6). These cytokines are key mediators of inflammation, and their suppression by Rebaudioside D suggests its potential role in modulating inflammatory responses in the body. Furthermore, animal models have demonstrated that dietary supplementation with Rebaudioside D can reduce inflammation-related markers in tissues such as the liver and adipose tissue.

The antioxidant activity of Rebaudioside D is another area of significant interest. Reactive oxygen species (ROS) are known to contribute to oxidative stress, which is implicated in the pathogenesis of various diseases including cancer, neurodegenerative disorders, and aging-related conditions. Studies have shown that Rebaudioside D can scavenge ROS and protect cells from oxidative damage. This protective effect is attributed to its ability to enhance the activity of endogenous antioxidant enzymes such as superoxide dismutase (SOD) and catalase.

Hypoglycemic effects have also been observed with Rebaudioside D. Research suggests that this compound can improve glucose metabolism by enhancing insulin sensitivity and reducing glucose absorption from the gastrointestinal tract. These effects make it a promising candidate for managing blood sugar levels in individuals with type 2 diabetes. Clinical trials are ongoing to evaluate the efficacy and safety of Rebaudioside D as a therapeutic agent for diabetes.

The safety profile of Rebaudioside D has been extensively evaluated due to its widespread use as a food additive. Regulatory agencies such as the U.S. Food and Drug Administration (FDA) and the European Food Safety Authority (EFSA) have deemed it safe for human consumption at acceptable daily intake levels. These assessments are based on numerous studies demonstrating its low toxicity and lack of adverse effects even at high doses.

The applications of Rebaudioside D extend beyond its use as a sweetener. Its bioactive properties make it suitable for inclusion in functional foods and nutraceutical products aimed at promoting health and preventing disease. For example, formulations containing Rebaudioside D are being developed as dietary supplements to support immune function, cardiovascular health, and metabolic balance.

In conclusion, Rebaudioside D (CAS No: 63279-13-0) strong>, derived from the stevia plant, is a versatile compound with significant potential in both food science and pharmaceuticals. Its natural sweetness combined with its array of biological activities positions it as a valuable ingredient for enhancing product appeal while providing health benefits. As research continues to uncover new applications for this natural glycoside, its role in promoting health and wellness is likely to expand further.

• 57817-89-7(Stevioside)
• 142543-22-4(9,13-Dihydroxy-16-kauren-19-oic acid; (ent-9α,13β)-form, 13-O-β-D-Glucopyranoside, β-D-glucopyranosyl ester)
• 64432-06-0(Dulcoside A)
• 127345-21-5(Rebaudioside G)
• 63550-99-2(Rebaudioside C)
• 63279-14-1(Rebaudioside E)
• 91722-21-3(Stevioside A3)
• 1220616-46-5(Rebaudioside N)
• 64849-39-4(Rubusoside)
• 58543-16-1(Rebaudioside A)